跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUGAMMADEX BAXTER SOLUTION FOR INJECTION 100 MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
SUGAMMADEX BAXTER SOLUTION FOR INJECTION 100 MG/ML
Approved
THERAPEUTIC
SUGAMMADEX BAXTER SOLUTION FOR INJECTION 100 MG/ML
Solupharm Pharmazeutische Erzeugnisse GmbH (GERMANY)
🇸🇬 Health Sciences Authority
Approval Date
Apr 4, 2026
Approval ID
41e0bea18168b001
Company
Solupharm Pharmazeutische Erzeugnisse GmbH (GERMANY)
Type
Therapeutic
Approval Details
Approval Id
41e0bea18168b001
Drug Name
SUGAMMADEX BAXTER SOLUTION FOR INJECTION 100 MG/ML
Product Name
SUGAMMADEX BAXTER SOLUTION FOR INJECTION 100 MG/ML
Approval Number
SIN17512P
Approval Date
2026-04-04
Registrant
BAXTER HEALTHCARE (ASIA) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
INTRAVENOUS
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 4, 2026
Approval ID
41e0bea18168b001
Type
Therapeutic
Back to HSA Approvals
